Clinical Trial Update: Crossover Clinical Trial, Randomized, Double Blind, Placebo Controlled Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled crossover trial in chronic kidney disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Maimónides Biomedical Research Institute of Córdoba | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED